TrialDiabetes, obesity & metabolism2021

Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD-11.

Juan P Frias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.